208 related articles for article (PubMed ID: 33196759)
1. A comparison of mRNA and circRNA expression between squamous cell carcinoma and adenocarcinoma of the lungs.
Yu M; Tian Y; Wu M; Gao J; Wang Y; Liu F; Sheng S; Huo S; Bai J
Genet Mol Biol; 2020; 43(4):e20200054. PubMed ID: 33196759
[TBL] [Abstract][Full Text] [Related]
2. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
Gao L; Zhang L
BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
[TBL] [Abstract][Full Text] [Related]
3. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.
Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ
J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071
[TBL] [Abstract][Full Text] [Related]
4. Identification of Differentially Expressed Circular RNAs as miRNA Sponges in Lung Adenocarcinoma.
Liu Y; Wang X; Bi L; Huo H; Yan S; Cui Y; Cui Y; Gu R; Jia D; Zhang S; Cai L; Li X; Xing Y
J Oncol; 2021; 2021():5193913. PubMed ID: 34539783
[TBL] [Abstract][Full Text] [Related]
5. RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma.
Wang C; Tan S; Liu WR; Lei Q; Qiao W; Wu Y; Liu X; Cheng W; Wei YQ; Peng Y; Li W
Mol Cancer; 2019 Sep; 18(1):134. PubMed ID: 31484581
[TBL] [Abstract][Full Text] [Related]
6. A Novel circRNA-miRNA-mRNA Hub Regulatory Network in Lung Adenocarcinoma.
Zuo H; Li X; Zheng X; Sun Q; Yang Q; Xin Y
Front Genet; 2021; 12():673501. PubMed ID: 34306017
[TBL] [Abstract][Full Text] [Related]
7. Identification of Novel circRNA-Based ceRNA Network Involved in the Pathogenesis of Gastric Cancer.
Peng D; Feng L; Li H
Int J Genomics; 2022; 2022():5281846. PubMed ID: 35685832
[TBL] [Abstract][Full Text] [Related]
8. Identification of circular RNA-microRNA-messenger RNA regulatory network in hepatocellular carcinoma by integrated analysis.
Sun X; Ge X; Xu Z; Chen D
J Gastroenterol Hepatol; 2020 Jan; 35(1):157-164. PubMed ID: 31222831
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of circRNA-miRNA-mRNA Network in Cervical Squamous Cell Carcinoma by Integrated Analysis.
Wu Q; Liu P; Lao G; Liu Y; Zhang W; Ma C
Onco Targets Ther; 2020; 13():8641-8650. PubMed ID: 32922040
[TBL] [Abstract][Full Text] [Related]
10. Construction and analysis of the ceRNA network
Yang Y; Zhang Y; Ding X; Ren Y; Wei B; Lin Z; Nie Y; Fan Y
Ann Transl Med; 2021 Dec; 9(24):1757. PubMed ID: 35071451
[TBL] [Abstract][Full Text] [Related]
11. Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma.
Tian Y; Yu M; Sun L; Liu L; Wang J; Hui K; Nan Q; Nie X; Ren Y; Ren X
J Comput Biol; 2020 Jul; 27(7):1067-1078. PubMed ID: 31750732
[TBL] [Abstract][Full Text] [Related]
12. A circular RNAs dataset landscape reveals potential signatures for the detection and prognosis of early-stage lung adenocarcinoma.
Chen Z; Wei J; Li M; Zhao Y
BMC Cancer; 2021 Jul; 21(1):781. PubMed ID: 34229638
[TBL] [Abstract][Full Text] [Related]
13. Identification of circRNA-miRNA-mRNA Regulatory Network in Bladder Cancer by Integrated Analysis.
Chen P; Chen J; He L; Du C; Wang X
Urol Int; 2021; 105(7-8):705-715. PubMed ID: 33789319
[TBL] [Abstract][Full Text] [Related]
14. LINC00628 is differentially expressed between lung adenocarcinoma and squamous cell carcinoma and is associated with the prognosis of NSCLC.
Liu T; Xu S; Liu X
Oncol Lett; 2022 Feb; 23(2):55. PubMed ID: 34992687
[TBL] [Abstract][Full Text] [Related]
15. hsa_circ_0000729, a potential prognostic biomarker in lung adenocarcinoma.
Li S; Sun X; Miao S; Lu T; Wang Y; Liu J; Jiao W
Thorac Cancer; 2018 Aug; 9(8):924-930. PubMed ID: 29932500
[TBL] [Abstract][Full Text] [Related]
16. Analysis of ceRNA network identifies prognostic circRNA biomarkers in bladder cancer.
Liu L; Wu SQ; Zhu X; Xu R; Ai K; Zhang L; Zhao XK
Neoplasma; 2019 Sep; 66(5):736-745. PubMed ID: 31169020
[TBL] [Abstract][Full Text] [Related]
17. Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma.
Cao B; Wang P; Gu L; Liu J
Oncol Lett; 2021 Apr; 21(4):249. PubMed ID: 33664813
[TBL] [Abstract][Full Text] [Related]
18. Identification of the key genes and characterizations of Tumor Immune Microenvironment in Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC).
Zhang L; Chen J; Cheng T; Yang H; Li H; Pan C
J Cancer; 2020; 11(17):4965-4979. PubMed ID: 32742444
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of IL-6R mRNA in lung adenocarcinoma and squamous cell carcinoma.
Xu B; Chen Q; Yue C; Lan L; Jiang J; Shen Y; Lu B
Oncol Lett; 2018 Sep; 16(3):2935-2948. PubMed ID: 30127882
[TBL] [Abstract][Full Text] [Related]
20. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
